Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK)
HKD 8.42
(0.0%)
HKD 8.42
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 413.75 Million HKD | -14.95% |
| 2022 | 486.48 Million HKD | 64.64% |
| 2021 | 295.47 Million HKD | 2.79% |
| 2020 | 287.45 Million HKD | -22.87% |
| 2019 | 372.68 Million HKD | 153.77% |
| 2018 | 146.85 Million HKD | -3.69% |
| 2017 | 152.47 Million HKD | 19.51% |
| 2016 | 127.58 Million HKD | 8.06% |
| 2015 | 118.07 Million HKD | 23.4% |
| 2014 | 95.68 Million HKD | -4.7% |
| 2013 | 100.39 Million HKD | -0.77% |
| 2012 | 101.17 Million HKD | 45.2% |
| 2011 | 69.67 Million HKD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 308.25 Million HKD | 0.0% |
| 2024 Q1 | 308.25 Million HKD | -25.5% |
| 2023 Q2 | 366.95 Million HKD | 0.0% |
| 2023 FY | 413.75 Million HKD | -14.95% |
| 2023 Q1 | 366.95 Million HKD | -24.57% |
| 2023 Q4 | 413.75 Million HKD | 0.0% |
| 2023 Q3 | 413.75 Million HKD | 12.75% |
| 2022 Q1 | 313.76 Million HKD | 6.19% |
| 2022 FY | 486.48 Million HKD | 64.64% |
| 2022 Q4 | 486.48 Million HKD | 0.0% |
| 2022 Q3 | 486.48 Million HKD | 55.05% |
| 2022 Q2 | 313.76 Million HKD | 0.0% |
| 2021 Q1 | 299.42 Million HKD | 4.16% |
| 2021 FY | 295.47 Million HKD | 2.79% |
| 2021 Q3 | 295.47 Million HKD | -1.32% |
| 2021 Q4 | 295.47 Million HKD | 0.0% |
| 2021 Q2 | 299.42 Million HKD | 0.0% |
| 2020 Q3 | 287.45 Million HKD | -23.3% |
| 2020 FY | 287.45 Million HKD | -22.87% |
| 2020 Q1 | 374.8 Million HKD | 0.57% |
| 2020 Q2 | 374.8 Million HKD | 0.0% |
| 2020 Q4 | 287.45 Million HKD | 0.0% |
| 2019 Q4 | 372.68 Million HKD | 0.0% |
| 2019 Q2 | 332.82 Million HKD | 0.0% |
| 2019 FY | 372.68 Million HKD | 153.77% |
| 2019 Q3 | 372.68 Million HKD | 11.98% |
| 2019 Q1 | 332.82 Million HKD | 126.63% |
| 2018 FY | 146.85 Million HKD | -3.69% |
| 2018 Q4 | 146.85 Million HKD | 0.0% |
| 2018 Q3 | 146.85 Million HKD | -32.08% |
| 2018 Q2 | 216.22 Million HKD | 0.0% |
| 2018 Q1 | - HKD | -100.0% |
| 2017 Q2 | 204.28 Million HKD | 0.0% |
| 2017 FY | 152.47 Million HKD | 19.51% |
| 2017 Q4 | 152.47 Million HKD | 0.0% |
| 2017 Q1 | - HKD | -100.0% |
| 2017 Q3 | - HKD | -100.0% |
| 2016 Q1 | - HKD | -100.0% |
| 2016 FY | 127.58 Million HKD | 8.06% |
| 2016 Q4 | 127.58 Million HKD | 0.0% |
| 2016 Q2 | 130.69 Million HKD | 0.0% |
| 2015 Q4 | 118.07 Million HKD | 0.0% |
| 2015 Q2 | 151.99 Million HKD | 0.0% |
| 2015 FY | 118.07 Million HKD | 23.4% |
| 2015 Q1 | - HKD | -100.0% |
| 2014 FY | 95.68 Million HKD | -4.7% |
| 2014 Q4 | 95.68 Million HKD | 0.0% |
| 2014 Q2 | 121.73 Million HKD | 0.0% |
| 2014 Q1 | - HKD | -100.0% |
| 2013 Q4 | 100.39 Million HKD | 0.0% |
| 2013 Q2 | 67.22 Million HKD | 0.0% |
| 2013 Q1 | - HKD | -100.0% |
| 2013 FY | 100.39 Million HKD | -0.77% |
| 2012 Q4 | 101.17 Million HKD | 0.0% |
| 2012 FY | 101.17 Million HKD | 45.2% |
| 2011 FY | 69.67 Million HKD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| China Healthwise Holdings Limited | 145.27 Million HKD | -184.814% |
| Tycoon Group Holdings Limited | 445.4 Million HKD | 7.106% |